NasdaqGM - Delayed Quote USD
Personalis, Inc. (PSNL)
At close: November 15 at 4:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHEN RICHARD Officer | Sale | Jul 30, 2024 | 127,227 |
| HALL CHRISTOPHER M Chief Executive Officer | Sale | Nov 1, 2024 | 178,098 |
| MOORE STEPHEN MICHAEL Officer | Sale | Jun 17, 2024 | 69,081 |
| MYERS WOODROW A JR Director | Purchase | Mar 1, 2024 | 26,116 |
| TACHIBANA AARON Chief Operating Officer | Sale | Jul 30, 2024 | 175,270 |
| TEMPUS AI INC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 16, 2024 | 12,718,800 |
| WEST JOHN STEPHEN Chief Executive Officer | Conversion of Exercise of derivative security | Dec 14, 2022 | 622,444 |
Related Tickers
CDNA CareDx, Inc
21.17
-1.76%
VCYT Veracyte, Inc.
35.94
-2.97%
TWST Twist Bioscience Corporation
36.89
-5.31%
GH Guardant Health, Inc.
29.11
-3.64%
BDSX Biodesix, Inc.
1.3450
-3.93%
GRAL GRAIL, Inc.
14.80
-6.39%
NTRA Natera, Inc.
146.06
-3.34%
ACRS Aclaris Therapeutics, Inc.
2.0500
-5.96%
MYGN Myriad Genetics, Inc.
15.25
-2.74%
EXAS Exact Sciences Corporation
49.33
-3.14%